For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Igm Biosciences, Inc.

USPTO Granted Patents = 21

CIPO Patents = 1

EPO Patents = 10

Trademarks = 3

Forward Citations = 140

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Bruce Alan Keyt (19 out of 42 patents)

Ramesh Baliga (15 out of 28 patents)

Leonard G Presta (10 out of 212 patents)

4. Fen Zhang (6 out of 10 patents)

5. Dean Ng (4 out of 4 patents)

6. Stephen Fitzhugh Carroll (3 out of 30 patents)

7. Ole Olsen (2 out of 33 patents)

8. Beatrice Tien-Yi Wang (2 out of 3 patents)

9. Marcia M Bieber (2 out of 7 patents)

10. Nelson N H Teng (2 out of 3 patents)

11. Dan T Stinchcomb (2 out of 57 patents)

12. Max Allen Schwarzer (2 out of 3 patents)

13. Neelima M Bhat (2 out of 7 patents)

14. Omar Duramad (1 out of 6 patents)

15. Rency Yoshimura (1 out of 1 patent)

21 patents: Sort by Forward Citations

1. 12486336 - BINDING MOLECULES WITH MODIFIED J-CHAIN (2025-12-02),

2. 11639389 - Binding molecules with modified J-chain (2023-05-02),

3. 11578131 - Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecules (2023-02-14),

4. 11555075 - Modified J-chain (2023-01-17),

5. 11542342 - Binding molecules with modified J-chain (2023-01-03),

6. 11535664 - Multi-valent hepatitis B virus antigen binding molecules and uses thereof (2022-12-27),

7. 11401337 - Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function (2022-08-02),

8. 11192941 - Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof (2021-12-07),

9. 10975147 - Modified J-chain (2021-04-13),

10. 10954302 - Anti-PD-L1 antibodies (2021-03-23),

11. 10899835 - IgM Fc and J-chain mutations that affect IgM serum half-life (2021-01-26),

12. 10822399 - IgA multi-specific binding molecules (2020-11-03),

13. 10787520 - Multimeric bispecific binding molecules specific for CD20 and CD3 (2020-09-29),

14. 10689449 - Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof (2020-06-23),

15. 10618978 - Binding molecules with modified J-chain (2020-04-14),

IGM Biosciences is a biotechnology company that specializes in the discovery and development of engineered antibodies for the treatment of cancer. With their proprietary IgM antibody technology, they aim to provide more effective and targeted therapies for patients. By leveraging their expertise in immunology and protein engineering, IGM Biosciences is dedicated to advancing the field of cancer treatment and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

21 Patents

#127 in Mountain View, CA

#3,635 in California

#15,202 in US

#29,122 in the World

Mountain View, CA, United States of America

Igm Biosciences, Inc.

Forward Citations = 140

17 inventors:

Bruce Alan Keyt (19 out of 42 patents)

Ramesh Baliga (15 out of 28 patents)

Leonard G Presta (10 out of 212 patents)

4. Fen Zhang (6 out of 10 patents)

5. Dean Ng (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…